Want to see IMUX full AI Analyst Report?
Total Valuation
Immunic has a market cap or net worth of $201.33M. The enterprise value is -$46.07M.
Market Cap$201.33M
Enterprise Value-$46.07M
Share Statistics
Immunic has 13,621,483 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,621,483
Owned by Insiders9.28%
Owned by Institutions<0.01%
Financial Efficiency
Immunic’s return on equity (ROE) is 14.56 and return on invested capital (ROIC) is 1693.37%.
Return on Equity (ROE)14.56
Return on Assets (ROA)-4.04
Return on Invested Capital (ROIC)1693.37%
Return on Capital Employed (ROCE)15.72
Revenue Per Employee0.00
Profits Per Employee-1.07M
Employee Count91
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Immunic is ―. Immunic’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio-12.46
Price to Fair Value-12.46
Price to FCF-0.97
Price to Operating Cash Flow-5.47
PEG Ratio0.02
Income Statement
In the last 12 months, Immunic had revenue of 0.00 and earned -97.17M in profits. Earnings per share was -6.24.
Revenue0.00
Gross Profit0.00
Operating Income-103.23M
Pretax Income-97.17M
Net Income-97.17M
EBITDA-97.00M
Earnings Per Share (EPS)-6.24
Cash Flow
In the last 12 months, operating cash flow was -81.33M and capital expenditures -116.00K, giving a free cash flow of -81.45M billion.
Operating Cash Flow-81.33M
Free Cash Flow-81.45M
Free Cash Flow per Share-5.98
Dividends & Yields
Immunic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change77.93%
50-Day Moving Average13.29
200-Day Moving Average9.69
Relative Strength Index (RSI)55.32
Average Volume (3m)207.04K
Important Dates
Immunic upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Immunic as a current ratio of 0.75, with Debt / Equity ratio of 0.28%
Current Ratio0.75
Quick Ratio0.75
Debt to Market Cap<0.01
Net Debt to EBITDA0.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Immunic has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Immunic EV to EBITDA ratio is -0.70, with an EV/FCF ratio of -0.79.
EV to Sales0.00
EV to EBITDA-0.70
EV to Free Cash Flow-0.79
EV to Operating Cash Flow-0.80
Balance Sheet
Immunic has $186.63M in cash and marketable securities with $421.00K in debt, giving a net cash position of $186.21M billion.
Cash & Marketable Securities$186.63M
Total Debt$421.00K
Net Cash$186.21M
Net Cash Per Share$13.67
Tangible Book Value Per Share-$0.43
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Immunic is $29.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$29.80
Price Target Upside2880.00% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast38.59%